Bountiful, not bubbly
Why this week’s flurry of biotech IPOs on NASDAQ isn’t a sign of market froth
A compressed calendar, rather than investor overexuberance, accounts for one of the busiest weeks for IPO pricings in the sector’s history.
Seven NASDAQ IPOs were completed during the week ending June 22, raising a total of $718.9 million before potential overallotments.
Five of the deals priced on June 20, making for the single most active day